Marico Just Cut the Price of Its Best Product. Volume Went Up 10%.

Every quote below is verbatim from company filings with its citation attached. This is a durability read, not a stock call.

What the market believes about pricing power

Ask an investor to prove a consumer company has pricing power and you will get the same test: can it raise prices without losing volume? It is a reasonable test. It is how brand strength is supposed to reveal itself — inflation arrives, the strong pass it through, the weak eat it, and the gross-margin line settles the argument.

On that test, Indian FMCG through FY25 and FY26 looked like a sector where pricing power was mostly a story about copra, palm oil and crude. When input costs ran, companies took price. When they took price, volumes wobbled. Analysts modelled elasticity, and the models mostly worked.

That is the consensus, stated at full strength. It is also incomplete, and Marico's own filings are where the gap shows.

The first gap

Here is what the company reported yesterday about its oldest, largest, most-scrutinised product:

"Parachute Rigids reported 10% volume growth, delivering one of its strongest performances in the recent years. Revenue grew 23% with price growth moderating as we took selective price actions to pass on value to consumers amidst easing copra prices."

— Q1 FY27 investor presentation, 4 August 2026, p.34

Read that twice. Copra — coconut oil's input — eased. Rather than bank the spread, Marico gave price back. And the volume response was the strongest in years.

Under the standard test, nothing here counts as pricing power. Prices went down. Under a better test, this is the cleanest demonstration of it in the sector this quarter.

What the market sees ⇄ what the evidence shows

The market sees a company enjoying a raw-material tailwind, and correctly notes that a copra downcycle flatters everyone in the category.

The evidence shows the tailwind was deliberately spent rather than pocketed. Passing input relief through is a choice, and it is the expensive one in any quarter where the alternative is a wider margin.

The market sees volume growth as the arithmetic consequence of a lower price. Cheaper goods sell better; there is nothing proprietary in that.

The evidence shows the elasticity relationship stopped behaving predictably for this brand a year ago — and management said so, against their own interest, on the record:

"the price elasticity model has got challenged in the last year because we were ourselves surprised because of the strong brand equity of Parachute that we are able to carry on a fl[at volume]"

— Earnings call, 12 May 2026, p.16

A management team volunteering that its own forecasting model broke — in the brand's favour — is the least likely thing to be spin.

The market sees a single-brand story, vulnerable to exactly this kind of input-cost swing.

The evidence shows the same quarter carrying share gains elsewhere in the portfolio, on a measure that cannot be bought with one quarter's discounting:

"Value-Added Hair Oils sustained its strong growth trajectory, registering 22% value growth during the quarter and increasing its value market share by 80 bps on a MAT basis."

— Q1 FY27 investor presentation, 4 August 2026, p.34

MAT — moving annual total — smooths a year. Share moving on that basis is not a promotion; it is a trend.

The mechanism that closes the gap

Here is the reframe the filings support. Pricing power is not the ability to raise prices. It is the ability to move price in either direction without the customer reconsidering the brand.

Weak brands are trapped in one direction. They can raise price only at the cost of volume, and cut price only at the cost of positioning — a discount teaches the customer the product was overpriced. Strong brands are free in both. They can take price when costs demand it and give it back when costs allow, and the customer reads both moves as fairness rather than as information about quality.

That freedom is what Marico appears to be exercising: price down, volume up 10%, share up 80 basis points on an annual basis. The margin cost is real and shows in the price-growth moderation. What is bought with it is the thing that makes the next price increase acceptable.

The honest side of the ledger

Two disclosures, because leaving them out would make this a worse argument. First, a falling input cost is a benign environment for this manoeuvre; the harder test comes when copra turns and the pass-through runs the other way, and the same filings note international markets facing "consumer demand softness amidst elevated inflation." Second, we have no deterministic moat score for Marico — this is a receipts-based read of one quarter's disclosures against management's own prior statements, not a scored verdict.

What to watch

Three things, each of which will appear in a future filing rather than in commentary:

1. The next up-cycle. When copra turns, does Marico take price back with the same volume resilience? That is the symmetric test.
2. Whether MAT share holds in value-added hair oils once the price action anniversaries — the gain has to survive its own base.
3. The international book, where the pricing doctrine meets markets without Parachute's brand equity to absorb it.

The question worth investigating yourself

If pricing power is really the freedom to move price in both directions, then most of the sector has never been tested on the downward half. Which of the consumer companies you follow have actually cut price into a falling input cycle — and what happened to their volumes when they did?

Related on MoatMargin: Marico first-pass note · The Moat Screener · MoatSCORE — how we score moats · Hindustan Unilever: the limits of a brand moat

MoatMargin Research publishes evidence, not advice. Every quote above is verbatim from company filings with its citation attached. Nothing here is a recommendation to buy or sell any security. We may be wrong; the receipts let you check.